DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
Un pódcast de DrugPatentWatch
100 Episodo
-
Key Factors for Choosing the Right CDMO
Publicado: 28/8/2023 -
Strategies to Maximize Product Value Amid Loss of Exclusivity in the Pharmaceutical Industry
Publicado: 21/8/2023 -
Unsuccessful Regulatory Filings for Biosimilar Approval: A Comprehensive Review
Publicado: 15/8/2023 -
Drug Patent Reports now available on Amazon
Publicado: 14/8/2023 -
Artificial Intelligence and Machine Learning in Drug Discovery and Development
Publicado: 10/8/2023 -
Prevalence and timing of authorized generics in the US market
Publicado: 8/8/2023 -
Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends
Publicado: 7/8/2023 -
The Evolution of Reverse Payment Cases: Courts and Agencies’ Approaches in Pharma Litigation
Publicado: 5/8/2023 -
Understanding the Impact of Authorized Generics on Drug Pricing: The Entacapone Case Study
Publicado: 2/8/2023 -
Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations
Publicado: 28/7/2023 -
DrugPatentWatch reveals NIH funding for patents
Publicado: 27/7/2023 -
Filing Strategies for Maximizing Pharma Patents
Publicado: 25/7/2023 -
DrugChatter Featured Questions
Publicado: 8/6/2023 -
DrugChatter.com: AI Chat for Biopharmaceutical Drug Insights
Publicado: 22/5/2023 -
NPR and DrugPatentWatch – Can drug injector pens be swapped?
Publicado: 16/5/2023 -
Utilizing 505(b)(2) Regulatory Pathway for New Drug Applications: An Overview on the Advanced Formulation Approach and Challenges
Publicado: 19/4/2023 -
Social Return on Investment
Publicado: 6/9/2022 -
CDCDB: A large and continuously updated drug combination database
Publicado: 7/6/2022 -
DrugPatentWatch named “Best of the Web” by Genetic Engineering News
Publicado: 2/5/2022 -
The value of method of use patent claims in protecting your therapeutic assets
Publicado: 5/4/2022
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management